Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$0.43 | -$0.26 | -$0.34 |
| Q2 2026 | 6 | -$0.29 | -$0.23 | -$0.25 |
| Q3 2026 | 5 | -$0.24 | -$0.11 | -$0.20 |
| Q4 2026 | 5 | -$0.12 | -$0.04 | -$0.11 |
| Q1 2027 | 1 | -$0.23 | -$0.21 | -$0.22 |
| Q2 2027 | 1 | -$0.20 | -$0.18 | -$0.19 |
| Q3 2027 | 1 | -$0.16 | -$0.14 | -$0.15 |
| Q4 2027 | 1 | -$0.10 | -$0.09 | -$0.10 |
| Q1 2028 | 2 | -$0.23 | -$0.21 | -$0.22 |
| Q2 2028 | 2 | -$0.19 | -$0.18 | -$0.19 |
| Q3 2028 | 2 | -$0.14 | -$0.13 | -$0.13 |
| Q4 2028 | 2 | -$0.07 | -$0.06 | -$0.07 |
Teladoc Health Inc last posted its earnings results on Wednesday, July 29th, 2026. The company reported $-0.21 earnings per share for the quarter, topping analysts' consensus estimates of $-0.24975 by $0.03975. The company had revenue of 606.93 M for the quarter and had revenue of 2.53 B for the year. Teladoc Health Inc has generated $-1 earnings per share over the last year ($-1.14 diluted earnings per share) and currently has a price-to-earnings ratio of -7.19. Teladoc Health Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 07/30/2026 | Q2 2026 | N/A | -$0.21 | N/A | $615.44 M | $606.93 M |
| 04/30/2026 | Q1 2026 | N/A | -$0.36 | N/A | N/A | $613.85 M |
| 02/26/2026 | Q4 2025 | N/A | -$0.14 | N/A | N/A | $642.27 M |
| 10/30/2025 | Q3 2025 | N/A | -$0.28 | N/A | $625.76 M | $626.44 M |
| 07/30/2025 | Q2 2025 | N/A | -$0.19 | N/A | $622.54 M | $631.90 M |
| 05/01/2025 | Q1 2025 | N/A | -$0.53 | N/A | N/A | $629.37 M |
| 02/27/2025 | Q4 2024 | N/A | -$0.28 | N/A | N/A | $640.49 M |
| 10/31/2024 | Q3 2024 | N/A | -$0.20 | N/A | $631.18 M | $640.51 M |
| 08/01/2024 | Q2 2024 | N/A | -$4.92 | N/A | $649.16 M | $642.44 M |
| 04/26/2024 | Q1 2024 | N/A | -$0.49 | N/A | $637.31 M | $646.13 M |
| 02/23/2024 | Q4 2023 | N/A | -$0.17 | N/A | N/A | $660.53 M |
| 10/27/2023 | Q3 2023 | N/A | -$0.35 | N/A | N/A | $660.24 M |
| 07/28/2023 | Q2 2023 | N/A | -$0.40 | N/A | N/A | $652.41 M |
| 05/02/2023 | Q1 2023 | N/A | -$0.42 | N/A | N/A | $629.24 M |
| 03/01/2023 | Q4 2022 | N/A | -$23.49 | N/A | N/A | $637.71 M |
| 11/02/2022 | Q3 2022 | N/A | -$0.45 | N/A | N/A | $611.40 M |
| 08/03/2022 | Q2 2022 | N/A | -$19.22 | N/A | N/A | $592.38 M |
| 05/02/2022 | Q1 2022 | N/A | -$41.58 | N/A | N/A | $565.35 M |
| 02/28/2022 | Q4 2021 | N/A | -$0.07 | N/A | N/A | $554.24 M |
| 11/01/2021 | Q3 2021 | N/A | -$0.53 | N/A | N/A | $521.66 M |
In the previous quarter, Teladoc Health Inc (:TDOC) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.24975 by $0.03975.
The conference call for Teladoc Health Inc's latest earnings report can be listened to online.
The conference call transcript for Teladoc Health Inc's latest earnings report can be read online.
Teladoc Health Inc (:TDOC) has a recorded annual revenue of $2.53 B.
Teladoc Health Inc (:TDOC) has a recorded net income of $-200,322,000.Teladoc Health Inc has generated $-1.14 earnings per share over the last four quarters.
Teladoc Health Inc (:TDOC) has a price-to-earnings ratio of -7.19 and price/earnings-to-growth ratio is -0.44.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED